ADPT · Adaptive Biotechnologies Corp
$24.74
+0.28 (+1.14%)
At close · Aug 14
Market Cap
$3.95B
Shares
159.60M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Chad Robins | Chief Executive Officer and Chairman | $9,081,690 |
| Harlan Robins | Chief Scientific Officer | $8,509,575 |
| Julie Rubinstein | President and Chief Operating Officer | $4,603,995 |
| Susan Bobulsky | Chief Commercial Officer, MRD | $3,547,558 |
| Kyle Piskel | Chief Financial Officer | $3,310,729 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Chad Robins | Chief Executive Officer and Chairman | $4,973,301 |
| Harlan Robins | Chief Scientific Officer | $4,540,286 |
| Julie Rubinstein | President and Chief Operating Officer | $2,644,553 |
| Sharon Benzeno | Chief Commercial Officer, IM | $1,796,594 |
| Susan Bobulsky | Chief Commercial Officer, MRD | $1,706,700 |
| Tycho Peterson | Former Chief Financial Officer | $1,667,102 |
| Kyle Piskel | Chief Financial Officer | $1,290,346 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Chad Robins | Chief Executive Officer and Chairman | $8,904,267 |
| Harlan Robins | Chief Scientific Officer | $8,611,805 |
| Julie Rubinstein | President and Chief Operating Officer | $2,971,039 |
| Sharon Benzeno | Chief Commercial Officer, IM | $2,880,721 |
| Tycho Peterson | Former Chief Financial Officer | $2,565,396 |
| Susan Bobulsky | Chief Commercial Officer, MRD | $1,455,155 |
| Kyle Piskel | Chief Financial Officer | $744,046 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Chad Robins | Chief Executive Officer and Chairman | $8,853,328 |
| Harlan Robins | Chief Scientific Officer | $8,459,087 |
| Julie Rubinstein | President and Chief Operating Officer | $6,535,078 |
| Tycho Peterson | Former Chief Financial Officer | $5,938,257 |
| Sharon Benzeno | Chief Commercial Officer, IM | $3,237,784 |
| Kyle Piskel | Chief Financial Officer | $1,659,147 |
| Chad Cohen | Former Chief Financial Officer | $72,221 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Chad Robins | Chief Executive Officer and Chairman | $8,751,617 |
| Harlan Robins | Chief Scientific Officer | $8,346,482 |
| Nitin Sood | Chief Commercial Officer, MRD | $6,389,270 |
| Julie Rubinstein | President and Chief Operating Officer | $5,815,939 |
| Chad Cohen | Former Chief Financial Officer | $2,911,839 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Chad Robins | Chief Executive Officer and Chairman | $7,131,118 |
| Harlan Robins | Chief Scientific Officer | $6,761,270 |
| Julie Rubinstein | President and Chief Operating Officer | $4,743,855 |
| Chad Cohen | Former Chief Financial Officer | $2,329,752 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kyle Piskel | Chief Financial Officer | Appointed | 2024-04-09 |
| Kyle Piskel | Chief Financial Officer | Appointed | 2024-04-02 |
| Tycho Peterson | Chief Financial Officer | Resigned | 2024-04-02 |
| Kevin Conroy | Board of Directors member | Resigned | 2023-09-01 |
| Nitin Sood | Chief Commercial Officer of the MRD business | Resigned | 2023-08-02 |
| Leslie Trigg | Board of Directors member | Resigned | 2023-06-13 |
| Mark Adams | Chief Operating Officer | Terminated | 2023-04-11 |
Key facts
CIK
1478320
CUSIP
00650F109
13F (30d)
286 filings
282 filers
Visit website
Investor relations